0000000000275903

AUTHOR

Damiano Caruso

0000-0001-9285-4764

showing 4 related works from this author

Structured reporting of rectal cancer staging and restaging: A consensus proposal

2021

Background: Structured reporting (SR) in oncologic imaging is becoming necessary and has recently been recognized by major scientific societies. The aim of this study was to build MRI-based structured reports for rectal cancer (RC) staging and restaging in order to provide clinicians all critical tumor information. Materials and Methods: A panel of radiologist experts in abdominal imaging, called the members of the Italian Society of Medical and Interventional Radiology, was established. The modified Delphi process was used to build the SR and to assess the level of agreement in all sections. The Cronbach’s alpha (Cα) correlation coefficient was used to assess the internal consistency of ea…

re-stagingCancer Researchmedicine.medical_specialtyStagingColorectal cancerIntraclass correlationModified delphiArticle030218 nuclear medicine & medical imaging03 medical and health sciencesRe‐staging0302 clinical medicineMagnetic resonance imagingmagnetic resonance imaging; rectal cancer; re‐staging; staging; structured reportingCronbach's alphaStructured reportingInternal consistencymedicineMedical physicsRectal cancerRC254-282Final versionmedicine.diagnostic_testbusiness.industryNeoplasms. Tumors. Oncology. Including cancer and carcinogensInterventional radiologymedicine.diseaseOncology030220 oncology & carcinogenesisbusinessStructured reporting
researchProduct

Imaging standardisation in metastatic colorectal cancer: a joint EORTC-ESOI-ESGAR expert consensus recommendation

2022

Background: Treatment monitoring in metastatic colorectal cancer (mCRC) relies on imaging to evaluate the tumor burden. Response Evaluation Criteria in Solid Tumors (RECIST) provide a framework on reporting and interpretation of imaging findings yet offer no guidance on a standardized imaging protocol tailored to mCRC patients. Imaging protocol heterogeneity remains a challenge for the reproducibility of conventional imaging endpoints and is an obstacle for research on novel imaging endpoints. Patients and methods: Acknowledging the recently highlighted potential of radiomics and artificial intelligence (AI) tools as decision support for patient care in mCRC, a multidisciplinary, internatio…

PROTOCOLCancer ResearchPositron emission tomographyArtificial intelligenceConsensusBEVACIZUMABMedizinImagingCancer -- ImagingHumansCRITERIAColon (Anatomy) -- Cancer -- TomographyComputed tomographyScience & TechnologyRadiomicsRectal NeoplasmsAbdomen -- Radiography -- Case studiesColon (Anatomy) -- Cancer -- TreatmentReproducibility of ResultsAbdomen -- Radiography -- StandardsOPEN-LABELColorectal cancerArtificial intelligence Standardisation Colorectal cancer Computed tomography Imaging Positron emission tomography RadiomicsOncologyColonic NeoplasmsSURVIVALStandardisationLife Sciences & Biomedicine
researchProduct

Imaging of metabolic and overload disorders in tissues and organs

2023

Metabolic and overload disorders are a heterogeneous group of relatively uncommon but important diseases. While imaging plays a key role in the early detection and accurate diagnosis in specific organs with a pivotal role in several metabolic pathways, most of these diseases affect different tissues as part of a systemic syndromes. Moreover, since the symptoms are often vague and phenotypes similar, imaging alterations can present as incidental findings, which must be recognized and interpreted in the light of further biochemical and histological investigations. Among imaging modalities, MRI allows, thanks to its multiparametric properties, to obtain numerous information on tissue compositi…

Fabry diseaseHemochromatosiRadiology Nuclear Medicine and imagingOverload disorderMetabolic disorderCTMRI
researchProduct

Diffusion-weighted imaging in oncology: An update

2020

To date, diffusion weighted imaging (DWI) is included in routine magnetic resonance imaging (MRI) protocols for several cancers. The real additive role of DWI lies in the “functional” information obtained by probing the free diffusivity of water molecules into intra and inter-cellular spaces that in tumors mainly depend on cellularity. Although DWI has not gained much space in some oncologic scenarios, this non-invasive tool is routinely used in clinical practice and still remains a hot research topic: it has been tested in almost all cancers to differentiate malignant from benign lesions, to distinguish different malignant histotypes or tumor grades, to predict and/or assess treatment resp…

OncologyCancer Researchmedicine.medical_specialtyReviewCancer imaginglcsh:RC254-282030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineMagnetic resonance imagingInternal medicinemedicineEffective diffusion coefficientcardiovascular diseasesapparent diffusion coefficient; cancer imaging; diffusion weighted imaging; magnetic resonance imaging; oncologic imagingmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingDiffusion weighted imaginglcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensOncologic imagingClinical PracticeOncologyApparent diffusion coefficient030220 oncology & carcinogenesisCancer imagingbusinessDiffusion MRI
researchProduct